Skip to main content

International Journal of Hematology

Ausgabe 2/2010

Inhalt (36 Artikel)

Images in Hematology

Paroxysmal nocturnal hemoglobinuria turning Coombs-positive

Alexander Röth, Sven Peine, Ulrich Dührsen

Images in Hematology

Incidence of koilonychia and atrophy of the lingual papillae in a patient with iron-deficiency anemia

Toru Takahashi, Koji Yamashita, Katsuhiro Hatao

Images in Hematology

Chest nodule in a patient with multiple myeloma

Bina E. Franklin, Mihaela Oprea, Sona M. Franklin

Progress in Hematology

Molecular aspects of myeloproliferative neoplasms

François Delhommeau, Dorota Jeziorowska, Christophe Marzac, Nicole Casadevall

Progress in Hematology

Therapy of myelofibrosis (excluding JAK2 inhibitors)

Alessandro Rambaldi

Progress in Hematology

The current status and the future of JAK2 inhibitors for the treatment of myeloproliferative diseases

Yasumichi Hitoshi, Nan Lin, Donald G. Payan, Vadim Markovtsov

Guideline

Guidelines for safety management of granulocyte transfusion in Japan

Akimichi Ohsaka, Atsushi Kikuta, Hitoshi Ohto, Akira Ohara, Akaru Ishida, Koji Osada, Tetsunori Tasaki, Akira Kamitamari, Asayuki Iwai, Shunro Kai, Taira Maekawa, Yasutaka Hoshi

Rapid Communication

mRNA expression of the XAGE-1 gene in human acute leukemia

Yuqiang Ji, Wanggang Zhang, Jin Wang, Liufang Gu

Original Article

Adult bone marrow cells can differentiate into hemopoietic cells and endothelial cells but not into other lineage cells in normal growth and normal life

Seiji Yanai, Yasushi Adachi, Ming Shi, Akio Shigematsu, Chieko Shima, Yuichiro Imai, A-Hon Kwon, Susumu Ikehara

Original Article

Sandwich ELISA for hemoglobin A2 quantification and identification of β-thalassemia carriers

Surakit Kuntaruk, Thanusak Tatu, Tiemjan Keowkarnkah, Watchara Kasinrerk

Original Article

Serum HO-1 is useful to make differential diagnosis of secondary hemophagocytic syndrome from other similar hematological conditions

Takuya Miyazaki, Yohei Kirino, Mitsuhiro Takeno, Maasa Hama, Ayumi Ushihama, Reina Watanabe, Kaoru Takase, Takayoshi Tachibana, Kenji Matsumoto, Masatsugu Tanaka, Satoshi Yamaji, Haruko Ideguchi, Naoto Tomita, Hiroyuki Fujita, Shigeru Ohno, Atsuhisa Ueda, Yoshiaki Ishigatsubo

Original Article

Glycosylation-modified erythropoietin with improved half-life and biological activity

Dongmei Su, Huilin Zhao, Huanzhang Xia

Original Article

Significance of immature platelet fraction and CD41-positive cells at birth in early onset neonatal thrombocytopenia

Hirotaka Kihara, Norioki Ohno, Syuhei Karakawa, Yoko Mizoguchi, Rie Fukuhara, Michiko Hayashidani, Shinji Nomura, Kazuhiro Nakamura, Masao Kobayashi

Original Article

Characterization of chronic idiopathic thrombocytopenic purpura in Japanese children: a retrospective multi-center study

Masaru Kubota, Souichi Adachi, Ikuya Usami, Masayuki Okada, Toshiyuki Kitoh, Mitsutaka Shiota, Yoshihiro Taniguchi, Akihiko Tanizawa, Mitsuhiko Nanbu, Keigo Hamahata, Hisanori Fujino, Kousaku Matsubara, Yoshihiro Wakazono, Tatsutoshi Nakahata

Original Article

Rituximab in combination with CHOP chemotherapy for the treatment of diffuse large B cell lymphoma in Japan: a retrospective analysis of 1,057 cases from Kyushu Lymphoma Study Group

Ritsuko Seki, Koichi Ohshima, Koji Nagafuji, Tomoaki Fujisaki, Naokuni Uike, Fumio Kawano, Hisashi Gondo, Shigeyoshi Makino, Tetsuya Eto, Yukiyoshi Moriuchi, Fumihiro Taguchi, Tomohiko Kamimura, Hiroyuki Tsuda, Ryosuke Ogawa, Kazuya Shimoda, Kiyoshi Yamashita, Keiko Suzuki, Hitoshi Suzushima, Kunihiro Tsukazaki, Masakazu Higuchi, Atae Utsunomiya, Masahiro Iwahashi, Yutaka Imamura, Kazuo Tamura, Junji Suzumiya, Minoru Yoshida, Yasunobu Abe, Tadashi Matsumoto, Takashi Okamura

Original Article

CD56 expression in human myeloma cells derived from the neurogenic gene expression: possible role of the SRY-HMG box gene, SOX4

Mohd S. Iqbal, Ken-ichiro Otsuyama, Karim Shamsasenjan, Hideki Asaoku, Michio M. Kawano

Original Article

Randomized trial of response-oriented individualized versus fixed-schedule induction chemotherapy with idarubicin and cytarabine in adult acute myeloid leukemia: the JALSG AML95 study

Shigeki Ohtake, Shuichi Miyawaki, Hitoshi Kiyoi, Yasushi Miyazaki, Hirokazu Okumura, Shin Matsuda, Tadashi Nagai, Yuji Kishimoto, Masaya Okada, Masatomo Takahashi, Hiroshi Handa, Jin Takeuchi, Shinichi Kageyama, Norio Asou, Fumiharu Yagasaki, Yasuhiro Maeda, Kazunori Ohnishi, Tomoki Naoe, Ryuzo Ohno

Original Article

Allogeneic stem cell transplantation versus chemotherapy as post-remission therapy for intermediate or poor risk adult acute myeloid leukemia: results of the JALSG AML97 study

Hisashi Sakamaki, Shuichi Miyawaki, Shigeki Ohtake, Nobuhiko Emi, Fumiharu Yagasaki, Kinuko Mitani, Shin Matsuda, Yuji Kishimoto, Yasushi Miyazaki, Norio Asou, Masatomo Takahashi, Yoshiaki Ogawa, Sumihisa Honda, Ryuzo Ohno

Original Article

Interaction of SDF-1α and CXCR4 plays an important role in pulmonary cellular infiltration in differentiation syndrome

Jin Zhou, Longhu Hu, Zhe Cui, Xian Jiang, Guifang Wang, Geoffrey W. Krissansen, Xueying Sun

Original Article

The clinical characteristics of CD7+ CD56+ acute myeloid leukemias other than M0

Ritsuro Suzuki, Shigeki Ohtake, Jin Takeuchi, Masami Nagai, Yoshihisa Kodera, Motohiro Hamaguchi, Shuichi Miyawaki, Takahiro Karasuno, Shigetaka Shimodaira, Ryuzo Ohno, Shigeo Nakamura, Tomoki Naoe

Original Article

Successful treatment of acute myelogenous leukemia with favorable cytogenetics by reduced-intensity stem cell transplantation

Takeshi Kondo, Atsushi Yasumoto, Kotaro Arita, Jun-ichi Sugita, Akio Shigematsu, Kohei Okada, Mutsumi Takahata, Masahiro Onozawa, Kaoru Kahata, Yukari Takeda, Masato Obara, Satoshi Yamamoto, Tomoyuki Endo, Mitsufumi Nishio, Norihiro Sato, Junji Tanaka, Satoshi Hashino, Takao Koike, Masahiro Asaka, Masahiro Imamura

Case Report

Autoimmune haemolytic anaemia associated with mantle cell lymphoma

Heather E. Eve, Simon A. J. Rule

Letter to the Editor

High-dose dexamethasone therapy for severe thrombocytopenia and neutropenia induced by EBV infectious mononucleosis

Yuki Kagoya, Akira Hangaishi, Tsuyoshi Takahashi, Yoichi Imai, Mineo Kurokawa

Letter to the Editor

Extreme eosinophilia caused by interleukin-5-producing disseminated colon cancer

Hiroki Kato, Katsura Kohata, Joji Yamamoto, Satoshi Ichikawa, Mika Watanabe, Kenichi Ishizawa, Ryo Ichinohasama, Hideo Harigae

Letter to the Editor

A case of congenital bone marrow failure with radio-ulnar synostosis

Hisao Yoshida, Yoshiko Hashii, Tokuko Okuda, Shigenori Kusuki, Emiko Sato, Akiko Inoue, Chihiro Kawakami, Miharu Yabe, Hideaki Ohta, Keiichi Ozono

Letter to the Editor

Effect of iron chelator deferasirox on chronic anemia and thrombocytopenia in a transfusion-dependent patient with myelodysplastic syndrome

Takamasa Nishiuchi, Yuichi Okutani, Toshikazu Fujita, Kazuya Yoshida, Hiroaki Ohnishi, Reiji Haba

Letter to the Editor

Rituximab therapy for refractory immune thrombocytopenic purpura in elder patients

Akira Hangaishi, Tsuyoshi Takahashi, Akiko Masuda, Sumitaka Okada, Koji Kandabashi, Mineo Kurokawa

Letter to the Editor

Non-cirrhotic extrahepatic portal vein thrombosis: a 6-year long case history

Giorgio Ricci, Flavia Pigò, Angelo Rossi, Gianluca Bersani, Vittorio Alvisi

Letter to the Editor

Monitoring plasma heparin concentration in a patient with antiphospholipid syndrome

Tohru Inaba, Yoichi Yuki, Sayuri Nishino, Shuhei Komatsu, Hidetaka Ishino, Hajime Tsuji, Naohisa Fujita

Letter to the Editor

Relevance of HBV/HBcAb screening in lymphoma patients treated in the Rituximab era

Davide Bedognetti, Gabriele Zoppoli, Mario Roberto Sertoli, Elisa Zanardi, Pietro Blandini, Lorenzo Uccellini, Francesco Boccardo, Giovanni Battista Andreoli, Riccardo Ghio, Omar Racchi, Manlio Ferrarini, Andrea De Maria

Letter to the Editor

Natural pregnancy and delivery after unrelated bone marrow transplantation using fludarabine-based regimen in a Fanconi anemia patient

Hiromasa Yabe, Takashi Koike, Takashi Shimizu, Hiroyuki Ishiguro, Tsuyoshi Morimoto, Hiromi Hyodo, Takeshi Akiba, Shunichi Kato, Miharu Yabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.